Literature DB >> 7317758

Elective delayed excision of bulky para-aortic lymph node metastases in advanced non-seminoma germ cell tumours of testis.

W F Hendry, P Goldstraw, J E Husband, A Barrett, T J McElwain, M J Peckham.   

Abstract

Forty-one patients with advanced non-seminoma germ cell testicular tumours were treated by chemotherapy, with or without radiotherapy, followed by excision of residual para-aortic lymph node masses. All para-aortic metastases were initially greater than 2 cm, 35 were larger than 5 cm, and 9 were over 10 cm in diameter. Seven patients also had nodal deposits above the diaphragm and 18 had distant metastases. The residual masses were excised completely in all except 3 cases. Residual malignancy was found in 7 (18%) of 38 operable cases; of these 7, only 2 remain alive and disease-free. In contrast, 28 (90%) of 31 operable cases with necrosis and fibrosis, or with fully differentiated teratoma, are alive and disease-free. Elevated serum markers were found in 6 of 9 cases with resectable or unresectable residual malignancy, but in only 1 of 32 who were tumour-free. Residual malignancy was found in 3 (9%) of 34 cases with normal marker levels. Malignancy was not found in any residual mass less than 4 cm diameter. We conclude that excision of para-aortic lymph node masses should be electively delayed until serum markers become normal and until shrinkage of the mass has ceased. The presence of residual malignancy in the excised tissue then provides a clear indication for further chemotherapy.

Entities:  

Mesh:

Year:  1981        PMID: 7317758     DOI: 10.1111/j.1464-410x.1981.tb03283.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

1.  Combination salvage chemotherapy using cisplatin and teniposide for patients with refractory germinal testicular tumors.

Authors:  T Kotake; T Miki
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?

Authors:  Stephen B Riggs; Earl F Burgess; Kris E Gaston; Caroline A Merwarth; Derek Raghavan
Journal:  Oncologist       Date:  2014-04-09

3.  A contribution to the treatment of non-seminomatous testicular tumours.

Authors:  J Base; P Navrátil
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

4.  Effect of chemotherapy on the histological appearances of testicular teratoma metastatic to the lung: correlation with patient survival.

Authors:  M Madden; P Goldstraw; B Corrin
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

5.  Preoperative staging of lung cancer: accuracy of computed tomography versus mediastinoscopy.

Authors:  P Goldstraw; M Kurzer; D Edwards
Journal:  Thorax       Date:  1983-01       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.